GALECTIN THERAPEUTICS INC - COM NEW (GALT)

Historical Holders from Q1 2014 to Q3 2025

Symbol
GALT on Nasdaq
Type / Class
Equity / COM NEW
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
10.3M
Holdings value
$43.7M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
83
Number of buys
36
Number of sells
-40
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of GALECTIN THERAPEUTICS INC - COM NEW (GALT)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 10.3M $43.7M -$59.9K $4.24 83
2025 Q2 10.5M $22.1M +$1.8M $2.11 84
2025 Q1 9.91M $12.1M -$167K $1.22 88
2024 Q4 10.1M $13M -$70.5K $1.29 94
2024 Q3 9.75M $26.8M +$626K $2.75 78
2024 Q2 9.42M $21.3M +$4.01M $2.26 71
2024 Q1 7.59M $18.1M +$1.15M $2.39 57
2023 Q4 7.22M $12M -$3.15M $1.66 66
2023 Q3 9.05M $17.4M +$3.46M $1.92 59
2023 Q2 7.27M $10.5M +$114K $1.44 58
2023 Q1 7.16M $15M +$222K $2.10 55
2022 Q4 7.11M $8.03M +$165K $1.13 58
2022 Q3 6.93M $11.3M -$167K $1.63 51
2022 Q2 7.05M $9.23M -$580K $1.31 53
2022 Q1 7.46M $12M -$281K $1.61 53
2021 Q4 7.33M $15.2M -$499K $2.07 52
2021 Q3 7.29M $28.2M -$2.24M $3.88 66
2021 Q2 7.89M $25.3M -$5.9M $3.20 70
2021 Q1 9.41M $20.4M -$1.89M $2.17 68
2020 Q4 10.8M $24M +$1.27M $2.24 74
2020 Q3 10M $26.8M -$334K $2.67 67
2020 Q2 10.2M $31.1M +$1.53M $3.06 73
2020 Q1 9.68M $19M -$1.08M $1.96 72
2019 Q4 10.1M $28.8M +$1.85M $2.86 75
2019 Q3 9.39M $34.4M +$3.02M $3.67 75
2019 Q2 8.48M $35.2M +$4.36M $4.15 71
2019 Q1 7.3M $37.3M +$9.16M $5.11 62
2018 Q4 5.73M $19.7M -$2.55M $3.43 57
2018 Q3 6.01M $36.1M +$2.41M $6.01 58
2018 Q2 5.57M $35.5M +$4.18M $6.36 66
2018 Q1 4.98M $23.6M +$6.25M $4.74 57
2017 Q4 3.73M $12.5M -$431K $3.34 45
2017 Q3 3.89M $8.3M -$6.44K $2.13 45
2017 Q2 3.83M $9.42M +$861K $2.46 44
2017 Q1 3.63M $8.34M +$2.11M $2.30 39
2016 Q4 2.85M $2.79M -$228K $0.98 35
2016 Q3 3.03M $3.43M -$602K $1.13 41
2016 Q2 3.5M $5.14M -$566K $1.47 44
2016 Q1 3.49M $4.98M -$243K $1.43 41
2015 Q4 3.59M $5.87M +$1.28M $1.64 49
2015 Q3 2.65M $7.02M -$1.74M $2.34 41
2015 Q2 3.33M $9.07M -$2.1M $2.73 52
2015 Q1 4.05M $13.6M +$950K $3.35 56
2014 Q4 3.76M $13M -$3.1M $3.47 58
2014 Q3 4.28M $21.5M -$4.78M $5.03 60
2014 Q2 4.24M $58.6M +$8.96M $13.81 61
2014 Q1 3.47M $53.1M +$31.9M $15.31 49